Group Cognitive Processing Therapy for Combat-related Posttraumatic Stress Disorder (PTSD)
|ClinicalTrials.gov Identifier: NCT01286415|
Recruitment Status : Completed
First Posted : January 31, 2011
Last Update Posted : March 27, 2017
|Condition or disease||Intervention/treatment||Phase|
|Posttraumatic Stress Disorder||Behavioral: Group Cognitive Processing Therapy-Cognitive Only Behavioral: Group Present Centered Therapy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||108 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Group Cognitive Processing Therapy for Combat-related PTSD|
|Study Start Date :||September 2008|
|Actual Primary Completion Date :||June 2013|
|Actual Study Completion Date :||June 2013|
|Experimental: Group Cognitive Processing Therapy-Cognitive Only||
Behavioral: Group Cognitive Processing Therapy-Cognitive Only
Cognitive Processing Therapy (CPT) is an evidence-based form of Cognitive Behavioral Therapy (CBT) used to treat PTSD. CPT is a 12-session manualized program that focuses on challenging beliefs and assumptions related to the trauma, oneself, and the world. Sessions will be conducted twice weekly for six weeks; each session is 90 minutes.
|Active Comparator: Group Present Centered Therapy||
Behavioral: Group Present Centered Therapy
Present Centered Therapy (PCT) is a supportive group intervention typically used within the Department of Veterans Affairs (VA) healthcare systems to address problems of veterans with PTSD (Rosen, et al., 2004). PCT focuses on problem-solving current difficulties that may be related to past traumatic events, but does not address specific memories or cognitions about the trauma. Sessions will be conducted twice weekly for 6 weeks; sessions are 90 minutes.
- Posttraumatic Stress Disorder Checklist-Stressor-specific Version (PCL-S) [ Time Frame: Baseline, weekly during treatment, posttreatment, 6-month and 12-month follow-up ]PCL-S measures symptoms of posttraumatic stress disorder in response to a specific stressor.
- Beck Depression Inventory-II [ Time Frame: Baseline, weekly during treatment, posttreatment, 6-month, and 12-month follow-up ]The BDI-II is one of the most widely used instruments for measuring the severity of depressive symptoms. It consists of 21 items that assess both affective and somatic symptoms related to depression and depressive disorders. Each item is composed of four statements that reflect symptom severity. The statements are scaled from 0 (no disturbance) to 3 (maximal disturbance). Scores on all items are summed to obtain a total severity score.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01286415
|United States, Texas|
|Fort Hood Army Base|
|Fort Hood, Texas, United States, 76544|
|Principal Investigator:||Patricia A Resick, PhD||Duke University|